Adults 18 years and older with 2 Diabetes needing insulin
A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients with Type 2 Diabetes
ORMD-0801
Study Length: 12 weeks
Target Age/Sex: 18 years and older, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
Link: ClinicalTrials.gov